Call Traders Blast These 2 Surging Stocks

Amarin's Vascepa got some more good news

Managing Editor
Nov 15, 2019 at 1:49 PM
facebook twitter linkedin

Stocks are scoring new highs to end the week, thanks to upbeat retail sales and chip sector earnings. Among two names making notable moves higher today are luxury retail concern Farfetch Ltd (NYSE:FTCH) and biopharmaceutical name Amarin Corporation (NASDAQ:AMRN). Here's a quick look at what's moving the shares of FTCH and AMRN.   

FTCH Call Traders Don't Envision a Post-Earnings Breather 

Farfetch stock is up 29.4% to trade at $9.68, on track for its best day ever and one of the better stocks on the New York Stock Exchange today. This comes after the retailer reported a third quarter loss that was slimmer than expected. Revenue topped expectations too, although five brokerages issued price-target cuts, the lowest coming out of Deutsche Bank to $14 from $31. FTCH is set to snap a five-day losing streak, but the rally has run out of steam at the shares' 80-day moving average. 

Options bulls appear undeterred. At last check, over 30,000 call options have changed hands, 10 times the expected intraday amount and 13 times the number of puts traded. Leading the charge is the November 10 call, which expires at the close today, but there are also new positions being opened at the December 9 call. 

Amarin Eyes Best Week Ever After More FDA News

Amarin stock is finishing its big week with a bang, last seen up 6.1% to trade at $22.80. A panel of experts to the Food and Drug Administration (FDA) unanimously voted to expand Vascepa, the company's heart disease drug, as additional therapy for patients with high risks of stroke and heart disease. On Monday, AMRN gapped higher after the FDA made encouraging comments about Vascepa. The shares are cruising toward a 33% weekly gain, its best ever, and are pennies away from its July 5 13-year high of $23.91.

Options traders were in overdrive on Monday, and are back at it again today. With just over three hours left in today's trading, 103,000 calls have changed hands, four times the average intraday amount and volume pacing for the 99th percentile of its annual range.


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!